or Try an Advanced Search...

    Technical Analysis for IVA - Inventiva S.A.

    Grade Last Price % Change Price Change
    F 3.67 3.09% 0.11
    IVA closed up 3.09 percent on Friday, May 31, 2024, on 2 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical IVA trend table...
    Date Alert Name Type % Chg
    MACD Bullish Signal Line Cross Bullish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Gapped Up Strength 0.00%
    MACD Bearish Signal Line Cross Bearish 3.09%
    20 DMA Support Bullish 3.09%
    50 DMA Support Bullish 3.09%
    Earnings Movers Other 3.09%
    Gapped Down Weakness 3.09%
    Older End-of-Day Signals for IVA ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 1 day ago
    Possible Inside Day 1 day ago
    Gap Up Partially Closed 1 day ago
    Gapped Up (Partial) 1 day ago
    Rose Above 10 DMA 1 day ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    IVA Chart by TradingView
    Basic chart:

    Profile

    Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Alcohol Genetics Gene Expression Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease DNA Fibrosis Small Molecule Therapies Transcription Transcription Factors Epigenetics Transcription Factor Hepatitis A

    Is IVA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 30 Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
    May 30 Statement of total voting rights and shares forming the company’s share capital as of May 13, 2024
    May 22 Inventiva announces two scientific presentations at the EASL International Liver Congress™ 2024
    May 21 Inventiva reports Q1 results
    May 21 Inventiva reports 2024 First Quarter Financial Information¹ and provides a corporate update
    May 17 Inventiva receives positive recommendation from DMC for late stage trial of NASH treatment
    May 16 Inventiva announces the positive recommendation of the fourth DMC of the NATiV3 Phase III clinical trial with lanifibranor in patients with MASH/NASH
    May 13 Why Is Inventiva's Stock Trading Higher on Monday?
    May 13 Inventiva announces the publication in Nature Communications of additional results from NATIVE Phase IIb clinical trial demonstrating improvement of markers of cardiometabolic health in patients with MASH/NASH treated with lanifibranor
    Apr 3 Inventiva announces filing of its 2023 Universal Registration Document and 2023 Annual Report on Form 20-F
    See more IVA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.04
    52 Week Low 3.05
    Average Volume 20,174
    200-Day Moving Average 3.84
    50-Day Moving Average 3.54
    20-Day Moving Average 3.58
    10-Day Moving Average 3.65
    Average True Range 0.20
    RSI (14) 54.13
    ADX 21.36
    +DI 23.31
    -DI 15.52
    Chandelier Exit (Long, 3 ATRs) 3.31
    Chandelier Exit (Short, 3 ATRs) 3.66
    Upper Bollinger Bands 3.86
    Lower Bollinger Band 3.29
    Percent B (%b) 0.66
    BandWidth 15.81
    MACD Line 0.04
    MACD Signal Line 0.04
    MACD Histogram 0.0018
    Fundamentals Value
    Market Cap 189.54 Million
    Num Shares 51.6 Million
    EPS -2.05
    Price-to-Earnings (P/E) Ratio -1.79
    Price-to-Sales 8.77
    Price-to-Book 2.64
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.67
    Resistance 3 (R3) 3.67 3.67 3.67
    Resistance 2 (R2) 3.67 3.67 3.67 3.67
    Resistance 1 (R1) 3.67 3.67 3.67 3.67 3.67
    Pivot Point 3.67 3.67 3.67 3.67 3.67
    Support 1 (S1) 3.67 3.67 3.67 3.67 3.67
    Support 2 (S2) 3.67 3.67 3.67 3.67
    Support 3 (S3) 3.67 3.67 3.67
    Support 4 (S4) 3.67